e-learning
resources
ERJ
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza
Schouten M., van der Sluijs K.F., Roelofs J.J.T.H., Levi M., van't Veer C., van der Poll T.
Source:
Eur Respir J 2010; 36: 1346-1354
Journal Issue:
December
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Schouten M., van der Sluijs K.F., Roelofs J.J.T.H., Levi M., van't Veer C., van der Poll T.. Factor V Leiden mutation does not affect coagulopathy or outcome in lethal H1N1 influenza. Eur Respir J 2010; 36: 1346-1354
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Risk of venous thromboembolism (VTE) in first degree relatives (FDRS) of patients with unprovoked VTE who do not have factor V Leiden (FVL) or the G20210A prothrombin gene mutation (PGM)
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Impact of recombinant factor VIIa (rFVIIa) on transfusion related acute lung injury (TRALI)
Source: Eur Respir J 2006; 28: Suppl. 50, 180s
Year: 2006
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 56 (4) 2000774; 10.1183/13993003.00774-2020
Year: 2020
The role of thrombophilic risk factors in the severity of pulmonary thromboembolism
Source: Eur Respir J 2002; 19: 709-711
Year: 2002
PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection
Source: Eur Respir J 2012; 39: 604-610
Year: 2012
The impact of screening for factor V Leiden (FVL) first degree relatives of patients with venous thromboembolism (VTE) and FVL on their risk of VTE
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Obesity as the most considerable risk factor for death due to influenza A/H1N1-09 viral infection
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL)
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Influenza type A outbreak associated with myositis
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Tumour necrosis factor and signal transducer and activator of transcription 3 pathways; novel targets to treat severe influenza virus infection
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
The G20210A polymorphism of the prothrombin gene is the strong genetic risk factor for the pulmonary embolism development in young patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004
H1N1pdm09 is an independent risk factor for severe influenza
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016
Higher plasma total homocysteine (tHcy) level and abnormal methionine loading test (MLT) in family members of patients with pulmonary embolism (PE) and carriers of factor V Leiden (FVL)
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004
Avian influenza and SARS – how much of a threat is it to humans and what can be done to prevent this?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005
Infection of human peribronchial gland cells (PBGC) with respiratory syncytial virus (RSV) shows a interaction of RSV with the nuclear factor (NF) κB-complex
Source: Eur Respir J 2001; 18: Suppl. 33, 305s
Year: 2001
Respiratory viral agents in cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
Nosocomial bacterial pneumonia in human immunodeficiency virus infected subjects: incidence, risk factors and outcome
Source: Eur Respir J 2001; 17: 636-640
Year: 2001
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis
Source: Eur Respir J 2003; 21: 25-30
Year: 2003
Prothrombin gene variant (20210A) as cause of thromboembolic events in a young pregnant woman
Source: Eur Respir J 2001; 18: Suppl. 33, 382s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept